palmidrol has been researched along with Parkinson Disease in 4 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petrosino, S | 1 |
| Schiano Moriello, A | 1 |
| Brotini, S | 1 |
| Schievano, C | 1 |
| Guidi, L | 1 |
| Crupi, R | 1 |
| Impellizzeri, D | 2 |
| Cordaro, M | 1 |
| Siracusa, R | 1 |
| Casili, G | 1 |
| Evangelista, M | 1 |
| Cuzzocrea, S | 2 |
| Esposito, E | 1 |
| Mazzon, E | 1 |
| Paterniti, I | 1 |
1 review available for palmidrol and Parkinson Disease
| Article | Year |
|---|---|
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
Topics: Alzheimer Disease; Amides; Amyotrophic Lateral Sclerosis; Animals; Autism Spectrum Disorder; Endocan | 2020 |
3 other studies available for palmidrol and Parkinson Disease
| Article | Year |
|---|---|
Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Amides; Antipsychotic Agents; Ethanolamines; Female; Humans; Levodopa; Male | 2017 |
N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; alpha-Synuclein; Amides; Animals; Behavior, Ani | 2018 |
Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease.
Topics: Amides; Animals; Astrocytes; bcl-2-Associated X Protein; Behavior, Animal; Catalepsy; Cell Membrane; | 2012 |